Intercure Ltd.
New Form D on file · 2026-08-19 · the record
Intercure Ltd. filed a Form D with the Securities and Exchange Commission on 2026-08-19.
Intercure Ltd. filed a Form D notice of an exempt securities offering with the SEC on August 19, 2026. Its industry group is Pharmaceuticals. It names Alexander Rabinovich (Chief Executive Officer and Chairman of the Board of Directors), David Salton (Director), Lennie Michelson Grinbaum (Director) (SEC Form D, August 19, 2026).
Is this your company?
Sell to companies like Intercure Ltd? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-08-19 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Intercure Ltd.
Free to see. No signup.
More on the people and the money behind Intercure Ltd., from the filings we hold.
Pharmaceuticals raises filed within 90 days of this one, largest first.
Get an email when Intercure Ltd. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Intercure Ltd. raises, hires or launches. No email unless you switch it on.
Watch Intercure Ltd. →Get the full cited report on Intercure Ltd.
What the filing shows about Intercure Ltd.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Intercure Ltd.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Intercure Ltd.'s address as 85 Medinat Ha-Yehudim St., Hertzliya, L3 4676670.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Intercure Ltd. is a registered filer with the SEC (CIK 1857030) and has filed since 2026-08-19. 1 filing is on record, the latest on 2026-08-19.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Intercure Ltd.'s Form D of 2026-08-19 names Alexander Rabinovich, David Salton, Lennie Michelson Grinbaum and 2 more as its officers, directors or promoters.
Trailing twelve months. 157 filings in Pharmaceuticals, totalled by week.
Checked away from the filing. What is below does not come from the record on sec.gov.
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
On the filing as: Executive Officer, Director.
Alexander Rabinovich is named as Chief Executive Officer and Chairman of the Board of Directors on the Form D that Intercure Ltd. filed with the SEC on 19 August 2026, one of 5 people that filing names.
David Salton is named as Director on the Form D that Intercure Ltd. filed with the SEC on 19 August 2026, one of 5 people that filing names.
Lennie Michelson Grinbaum is named as Director on the Form D that Intercure Ltd. filed with the SEC on 19 August 2026, one of 5 people that filing names.
Gideon Hirschfeld is named as Director on the Form D that Intercure Ltd. filed with the SEC on 19 August 2026, one of 5 people that filing names.
On the filing as: Executive Officer.
Amos Cohen is named as Chief Financial Officer on the Form D that Intercure Ltd. filed with the SEC on 19 August 2026, one of 5 people that filing names.
5 people named on the filing — 2 holding an executive role and 3 as directors only.
Named as of the 2026-08-19 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Intercure Ltd.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Intercure Ltd.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Intercure Ltd. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Intercure Ltd.You get an alert in MentionFox the next time this company shows up.
If you're behind Intercure Ltd.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-09-26 (intercure.co).
Each opens in a new tab, filled in for Intercure Ltd.. With no account yet, you sign up free and land on the result.
On these lists: Outside the US raises, week of 2026-08-17
https://mentionfox.com/funding/intercure-ltd-form-d-26000001